You are here: Home / Archives for NEWS BLOG . . . . . . . .

No autoimmune safety signal after vaccination with quadrivalent HPV vaccine Gardasil?

May 7, 2012 By 1 Comment

[SaneVax: The following article excerpt is from a letter to the editor of the Journal of Internal Medicine written by Lucija Tomljenovic and Christopher A. Shaw. Both are research scientists at the University of British Columbia. The excerpt was provided with their kind permission.]

Letter by Lucija Tomljenovic1, Christopher A Shaw1,2,3

1Neural Dynamics Research Group, Department of Ophthalmology and Visual Sciences,
University of British Columbia, 828 W. 10th Ave, Vancouver, BC, V5Z 1L8, Canada
1Neural Dynamics Research Group, Department of Ophthalmology and Visual Sciences,
2Department of Experimental Medicine and the 3Graduate Programme in Neuroscience,
University of British Columbia, 828 W. 10th Ave, Vancouver, BC, V5Z 1L8, Canada

‘Accepted Article’, doi: 10.1111/j.1365-2796.2012.02551.x
© 2012 The Association for the Publication of the Journal of Internal Medicine

Excerpt:

We have previously pointed out to existing HPV vaccine-related safety concerns as well as uncertainties about the efficacy of HPV vaccination against actual cervical cancer incidence [3, 4]. While results from clinical trials show that Gardasil can reduce the incidence of a subset of abnormal CIN 2/3+ cytologies (i.e., those related to HPV-16/18) in women with no pre-existing HPV infections [5], the vaccine is unlikely to reduce the overall frequency of cervical cancers (at least not beyond what Pap screening has already accomplished) [6, 7], yet this is the primary aim for which the vaccine was developed [8]. Furthermore, current data show that antibodies against HPV-18 after Gardasil fall rapidly, with 35% of women having no measurable antibody titers by 5 years post injection [6]. This outcome suggests that rather than preventing future cases of cervical cancer, Gardasil, at best, may only be effective in postponing them.

Access the entire letter via this link.

 

Filed Under: Gardasil / Silgard, Vaccine Science, World News Tagged With: , , ,

HPV Vaccination Completion Rate Shows Sharp Decline

May 7, 2012 By 2 Comments

[SaneVax: Are medical consumers in the U.S. 'just saying no' to HPV vaccines? A recent study indicates HPV vaccinations are being completed at a far lower rate than expected. In some age groups the completion rate in the United States dropped over 60% from 2006-09. Nevertheless, the so-called miracle cures for cervical cancer, Gardasil and Cervarix, are still being aggressively marketed to developing countries around the globe. One can only hope government health officials in these countries pay more attention to the 'science' behind these vaccines than marketing hype. After all, they have a duty to protect the health and safety of their population and an obligation to use precious health care money wisely.]

HPV vaccine completion rate among girls is poor, getting worse

From an article in medicalxpress.com

no-gardasil

No HPV Vaccines?

The proportion of insured girls and young women completing the human papillomavirus (HPV) vaccine among those who initiated the series has dropped significantly – as much as 63 percent – since the vaccine was approved in 2006, according to new research from the University of Texas Medical Branch (UTMB) in Galveston.

The study, published in the current issue of Cancer, reveals the steepest decline in vaccine completion among girls and young women aged nine to 18 – the age group that derives the greatest benefit from the vaccine, which should be administered in three doses over six months.

“The first generation of women that could benefit from the only HPV-related cancer vaccine in existence is missing the opportunity,” said lead author Abbey B. Berenson, director of the Center for Interdisciplinary Research in Women’s Health (CIRWH) at UTMB. “This vaccine prevents one of the most devastating cancers in women.”

Researchers examined a large health insurance company’s records of 271,976 female patients aged nine and older who received the first dose of the HPV vaccine between 2006 and 2009. Of this full sample, just 38.2 percent received all three doses within 365 days. In all but one age group (27 and older), researchers uncovered a marked drop in the number of females who completed the vaccine series:

HPV Vaccine Completion Rates (source: UTMB)
Age       2006      2009      Completion Dec/Inc
9-12      57.5%     21.2%           – 63%

13-18   54.9%      20.8%          - 62%

19-26   44.3%      22.6%          - 49%

27+       15%          24.5%         + 37%

Read the entire article here.

Filed Under: HPV, United States Tagged With: , , ,

Gardasil and Cervarix: Reasons for Caution Still Exist

May 6, 2012 By Leave a Comment

[SaneVax: In 2008, Dr. Charlotte Haug urged caution when considering implementation of HPV (human papillomavirus) vaccination programs. Not many people in the medical establishment appeared to listen. Four years later, those reasons for caution still exist, with a few new ones added. Please take a few minutes to read Dr. Haug's letter to the editor of the New England Journal of Medicine. Educate yourself before consenting to any medical intervention, including HPV vaccines.]

Human Papillomavirus Vaccination – Reasons for Caution

By Charlotte Haug, MD, PhD, (N Engl J Med 2008; 359:861-862 August 21, 2008)

HPV Vaccination Concerns

Despite great expectations and promising results of clinical trials, we still lack sufficient evidence of an effective vaccine against cervical cancer. Several strains of human papillomavirus (HPV) can cause cervical cancer, and two vaccines directed against the currently most important oncogenic strains (i.e., the HPV-16 and HPV-18 serotypes) have been developed. That is the good news. The bad news is that the overall effect of the vaccines on cervical cancer remains unknown. As Kim and Goldie1 point out in this issue of the Journal, the real impact of HPV vaccination on cervical cancer will not be observable for decades.

Although it was licensed for use in the United States in June 2006, the first phase 3 trials of the HPV vaccine with clinically relevant end points — cervical intraepithelial neoplasia grades 2 and 3 (CIN 2/3) — were not reported until May 2007, first in the Journal 2 and 1 month later in theLancet.3,4 The vaccine was highly successful in reducing the incidence of precancerous cervical lesions caused by HPV-16 and HPV-18, but a number of critical questions remained unanswered.5,6 For instance, will the vaccine ultimately prevent not only cervical lesions, but also cervical cancer and death? How long will protection conferred by the vaccine last? Since most HPV infections are easily cleared by the immune system, how will vaccination affect natural immunity against HPV, and with what implications? How will the vaccine affect preadolescent girls, given that the only trials conducted in this cohort have been on the immune response? The studies with clinical end points (i.e., CIN 2/3) involved 16- to 24-year-old women. How will vaccination affect screening practices? Since the vaccines protect against only two of the oncogenic strains of HPV, women must continue to be screened for cervical lesions. Vaccinated women may feel protected from cervical cancer and may be less likely than unvaccinated women to pursue screening. How will the vaccine affect other oncogenic strains of HPV? If HPV-16 and HPV-18 are effectively suppressed, will there be selective pressure on the remaining strains of HPV? Other strains may emerge as significant oncogenic serotypes.

Read the entire letter here.

Filed Under: HPV, HPV Science, Immunization Practices, World News Tagged With: , , , ,

Does Your Child’s Education Depend on Vaccination Status?

May 6, 2012 By 2 Comments

[SaneVax:  As school officials are advertising "No Shots, No School," vaccine safety advocates across the country are raising awareness of the vaccine exemptions that exist for every American child. It is simply not logical that any medical intervention, including vaccines, can be administered on a one-size-fits-all basis. Your child has an individual medical history. That is the reason for medical exemptions. Religious and philosophical exemptions also exist but vary widely from state to state. Only you and your medical professional can protect your child's health. Know your rights. Educate before you vaccinate.]

No jab, no education: New CA law requires middle schoolers to provide proof of Tdap vaccination in  order to receive education

By Ethan A. Huff, staff writer, Natural News

A new amendment to California’s Health and Safety Code as it relates to vaccinations will take effect this fall for the 2012-2013 school year, and will require all incoming seventh graders, as well as eighth and twelfth graders for the first year, to get a Tdap booster vaccination for pertussis (whooping cough) before being admitted to school. The website of the Marin County School District, which includes the city of San Francisco, literally states “No shot, No School!” in an apparent attempt to strong-arm parents into complying with the new provision.

Even though students in California can be exempted from any and all vaccinations for medical or personal reasons, most parents are largely unaware of this fact.

Read the entire article here.

Filed Under: Tdap, United States, Vaccine Politics/People Tagged With: , ,

HPV Vaccines versus Pap Screening

May 6, 2012 By 1 Comment

[SaneVax: March 12, 2012, the ASCP  released new pap screening guidelines. According to Dr. Mark Stoler, past president of ASCP, said, "The Pap test remains among the most effective tools ever devised to prevent cancer and cancer deaths."

Please note the fifth bullet point in the excerpt below. Obviously, Dr. Stoler and the American Society of Clinical Pathologists have never heard the saying, "If its not broke, don't fix it." Or, could it be they have simply become marketing agents for the manufacturers of HPV vaccines?]

To Pap or Not to Pap: What the New Cervical Cancer Screening Guidelines Mean for Women

Excerpt from a Press Release by the ASCP

New Cervical Cancer Screening Guidelines Now Available at http://ajcp.ascpjournals.org/.

Following is what women need to know about the new guidelines and recommendations for cervical cancer screening:

  • Not until age 21: Women shouldn’t get a Pap test until they’re 21 years old, even if they’ve been sexually active.
  • Every three years: Women should have a Pap test once every three years from ages 21 to 29.
  • After age 30: After 30, women should have a Pap test combined with testing for HPV every five years. HPV is a virus that can cause cervical cancer. An acceptable alternative is to continue having a Pap test alone every three years.
  • Over age 65: Women over 65 should stop getting cervical cancer screening tests altogether, as long as they’ve had at least three consecutive normal Pap tests or two negative HPV tests in the previous 10 years (the most recent in the previous five years), unless they have a history of pre-cancer. In that case, women should continue routine screening for 20 years.
  • HPV vaccination isn’t a factor: Whether or not a woman has had the HPV vaccine, she should continue to follow the above recommendations because the vaccine does not protect against all HPV strains that can cause cervical cancer.
  • After hysterectomy: If a woman has had a hysterectomy and the cervix was removed, she should not be screened at all, as long as there is no history of pre-cancer.

Read the entire press release here.

Filed Under: Cervical Cancer, Pap Testing Tagged With: , , ,

Gardasil: Weak Science, Strong Marketing?

May 6, 2012 By Leave a Comment

[SaneVax: Author Jeanne Lenzer tells it like it is - there are better ways to spend billions of dollars than on Gardasil. There is already an effective way to prevent cervical cancer deaths; it's called a Pap Smear. It would make more sense to extend this service to the poor, who are more likely to die from cervical cancer due to lack of screening.

Ms Lenzer questions the promotion of vaccines, drugs and medical devices that aren't backed up by solid clinical evidence and shown to be cost-effective in the real world.]

Should Boys Be Given the HPV Vaccine? The Science Is Weaker than the Marketing

By Jeanne Lenzer, Discover Magazine

Gardasil: Genetically Engineered

Valuable to Whom?

Merck’s promotion of Gardasil, its vaccine against the human papilloma virus (HPV), has a complicated history. First there was the exuberant claim about its reputedly great effectiveness in preventing cervical cancer. Now comes the recommendation last month from the Centers for Disease Control and Prevention, that all 11- and 12-year-old boys should be given the vaccine.

Of Science and Truthiness

The vaccine for boys is important, say advocates, because reducing HPV in boys will reduce transmission to girls and women—only 32 percent of whom have been getting the shots to date. Giving the shots to boys, they say, promotes gender equity. As a bonus, the vaccine may protect against oral and anal cancers in men who have sex with men.

Since a key part of the rationale for vaccinating boys is to protect girls, it’s worth a moment to examine the claims about reducing cervical cancer deaths. Merck won approval for Gardasil from the Food and Drug Administration in June 2006. On May 10, 2007, Merck published the results of a study in the New England Journal of Medicine that claimed an astounding 98 percent efficacy in preventing changes in the cervix used as a marker for cervical cancer.

But that statistic begs closer examination.

To achieve the 98 percent efficacy claim, Merck excluded from analysis anyone who “violated” the study protocol. In other words, all real-world problems that arose were excluded from analysis. Problems like girls who refused to take a second or third shot after they became sick and (correctly or incorrectly) blamed the vaccine. Or doctors who incorrectly gave the vaccine to someone who shouldn’t have received it.  While it’s worth knowing how effective the vaccine is when it’s used exactly as it should be, for a public-health decision, it’s not as relevant as its real-world effectiveness.

To Merck’s credit, they reported that when all women in the study were analyzed, the vaccine’s efficacy dropped to 44 percent. Still, 44 percent might be considered a smashing success when you’re talking about saving lives. Except for one thing: the numbers get worse. The 44 percent benefit included only those women with the two specific cancer-causing HPV strains found in the vaccine. But when the researchers looked at negative cervical changes from any causes, they found that changes occurred in unvaccinated women at a rate of 1.5 events per 100 person-years, while vaccinated women had 1.3 events—dropping the benefit to 17 percent.

Read the entire article here.

Filed Under: Gardasil / Silgard, Vaccine Marketing, World News Tagged With: , , ,

Do Vaccine Preventable Diseases Exist?

May 5, 2012 By 4 Comments

[Sanevax: Why were there only 930 cases of paralytic disease, all called polio, at the beginning of the polio eradication campaign in the Americas and 2,000 cases five years later, only six of which were diagnosed as polio? Are 'vaccine preventable' diseases being re-named to protect vaccination programs? Read the following article, then decide for yourself.]

Doctors Change Names of Diseases When Vaccines Do Not Work

By Christina England, Vactruth

Polio: Eradication or Anonymity?

Doctors around the world are being faced with children catching the diseases they have been vaccinated against. Rather than diagnosing these children correctly, professionals have discovered that the doctors are giving the diseases new names. This suggests a cover up is going on and the vaccinations we are all being told are safe and effective are in fact completely useless.

Vaccinations are now being given to children to keep them safe from every disease known to man. There appears to be a vaccination for everything from polio to a broken finger nail. However, many professionals now believe that the vaccinations are actually causing the diseases they are supposed to prevent.

It appears that they could be right because news has just been released that 47,500 children became paralyzed after polio vaccinations in India in 2011. According to Dr Jacob a member of the national technical advisory group on immunization and of the working group on the food and drug regulation in 2011 after receiving the polio vaccination, an additional 47,500 children were newly paralyzed, over and above the standard rate of 2 children per 100,000 non-polio AFP (acute flaccid paralysis) cases. (1)

Dr Viera Scheibner is a professional who would not be at all surprised at the above figures. She has firmly believed for many years that contrary to the belief that vaccinations prevent children from becoming ill, they are causing children to catch the diseases that they are being vaccinated against. She best explains this in her extremely well written letter published recently in the British Medical Journal (BMJ). (2) Her letter on the subject of polio vaccinations contains outstanding research and opens a gigantic can of worms that will be difficult for the pharmaceutical industries to ignore. In answer to an article titled ‘Polio eradication: a complex end game – Polio Eradication by Vaccination,’ she wrote:

“Polio eradication by vaccination?

Let me quote some original seminal medical research.

Anderson et al. (1951) in his article “Poliomyelitis occurring after antigen injections” (Pediatrics; 7(6): 741-759) wrote “During the last year several investigators have reported the occurrence of poliomyelitis after  a few weeks after injection of some antigen. Martin in England noted 25 cases in which paralysis of a single limb occurred within 28 days of injection of antigen into that limb, and two cases following penicillin injections.”

Read the entire article here.

Filed Under: Vaccines, World News

Ethics Violations During HPV Vaccine Trials in India: Punitive Action Anticipated

May 3, 2012 By 2 Comments

[SaneVax: Last year India called a halt to two clinical trials of HPV vaccines being conducted under the title of 'demonstration projects' due to allegations of multiple serious ethics and safety violations. After much investigation, the Union health ministry is expected to initiate punitive actions. Let's hope health authorities in other countries are watching, paying attention, and beginning their own investigations.]

Health ministry to initiate action against violations in HPV vaccine trial soon

By Ramesh Shankar, Mumbai

Will India Say No?

The Union health ministry will soon initiate punitive action against violations in the clinical trial of human papilloma virus vaccines (HPV vaccines) in Andhra Pradesh and Gujarat in early 2010 in which six children were allegedly died after they were administered the controversial vaccine being marketed by MSD Pharmaceuticals (Gardasil) and GSK Pharmaceuticals (Cervarix).

Sources in the union health ministry said that the files regarding this issue are being examined by the senior officials in the ministry and there will be some action on the issue very soon.

After the alleged deaths of six children, the trials were suspended on April 7, 2010 and the Union health ministry appointed a three-member expert committee to investigate ethical issues raised in the matter.

The final report of the panel had ruled out direct linkage between the deaths and the trials held in Khammam (where 13, 791 girls were vaccinated) and Gujarat’s Vadodara (where 9,637 were vaccinated). But at the same time, it said “the reported deaths were most probably unrelated to the vaccine. However, the cause of death in all cases could not be established with certainty”.

Read the entire article here.

 

Filed Under: Cervarix, Clinical Trials, Gardasil / Silgard, India, Vaccine Litigation Tagged With: , , ,

Whooping Cough: Vaccine Preventable Disease?

April 25, 2012 By Leave a Comment

[SaneVax: Whooping cough outbreaks are becoming more and more common. If this is because of vaccination opt-outs, why are the vast majority of cases in California occurring in a fully vaccinated population?]

 

Big Surprise – Whooping Cough Spreads Mainly through Vaccinated Populations, by Dr. Mercola

(17 April 2012)

Pertussis Vaccine effective?

In 2010, the largest outbreak of whooping cough in over 50 years reportedly occurred in California.

Around that same time, a scare campaign was launched in the California by Pharma-funded medical trade associations, state health officials and national media targeting people opting out of using pertussis vaccine, falsely accusing them of causing the then-current whooping cough outbreak.

But new research released last month paints a very different picture than the one being spread by the media.

In fact, the study showed that 81 percent of 2010 California whooping cough cases in people under the age of 18 occurred in those who were fully up to date on the whooping cough vaccine.

Read the entire article here.

 

Filed Under: Pertussis Vaccines, United States, Vaccine Marketing Tagged With: , ,
« Older Posts
Newer Posts »

Safety Videos

sanevax-videos

Victim Videos

sanevax-videos2

Pharma Videos

cervarix 2

Vaccine Groups

center-for-personal-rights-logo

SaneVax Press Releases

Logo 1A